Search Results - "M K Hellerstein"

Refine Results
  1. 1

    Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study by Beysen, C., Murphy, E. J., Deines, K., Chan, M., Tsang, E., Glass, A., Turner, S. M., Protasio, J., Riiff, T., Hellerstein, M. K.

    Published in Diabetologia (01-02-2012)
    “…Aims/hypothesis The primary aim of this completed multicentre randomised, parallel, double-blind placebo-controlled study was to elucidate the mechanisms of…”
    Get full text
    Journal Article
  2. 2

    Changes in microtubule turnover accompany synaptic plasticity and memory formation in response to contextual fear conditioning in mice by Fanara, P, Husted, K.H, Selle, K, Wong, P.-Y.A, Banerjee, J, Brandt, R, Hellerstein, M.K

    Published in Neuroscience (16-06-2010)
    “…Abstract Synaptic plasticity plays a crucial role in learning, memory, and cognitive disorders. Cytoskeletal reorganization underlies neuronal synaptic…”
    Get full text
    Journal Article
  3. 3

    De novo lipogenesis in humans: metabolic and regulatory aspects by Hellerstein, M K

    Published in European journal of clinical nutrition (01-04-1999)
    “…The enzymatic pathway for converting dietary carbohydrate (CHO) into fat, or de novo lipogenesis (DNL), is present in humans, whereas the capacity to convert…”
    Get full text
    Journal Article
  4. 4

    Carbohydrate-induced hypertriacylglycerolemia : historical perspective and review of biological mechanisms by PARKS, E. J, HELLERSTEIN, M. K

    Published in The American journal of clinical nutrition (01-02-2000)
    “…Current trends in health promotion emphasize the importance of reducing dietary fat intake. However, as dietary fat is reduced, the dietary carbohydrate…”
    Get full text
    Conference Proceeding Journal Article
  5. 5

    Effects of modified alternate-day fasting regimens on adipocyte size, triglyceride metabolism, and plasma adiponectin levels in mice by Varady, K.A., Roohk, D.J., Loe, Y.C., McEvoy-Hein, B.K., Hellerstein, M.K.

    Published in Journal of lipid research (01-10-2007)
    “…Calorie restriction (CR) affects adipocyte function and reduces body weight. However, the effects of alternate-day fasting (ADF) on adipose biology remain…”
    Get full text
    Journal Article
  6. 6

    Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice by Turner, S M, Roy, S, Sul, H S, Neese, R A, Murphy, E J, Samandi, W, Roohk, D J, Hellerstein, M K

    “…Recent evidence has been presented that expression of lipogenic genes is downregulated in adipose tissue of ob/ob mice as well as in human obesity, suggesting…”
    Get more information
    Journal Article
  7. 7

    Modified alternate‐day fasting regimens reduce cell proliferation rates to a similar extent as daily calorie restriction in mice by Varady, K. A., Roohk, D. J., McEvoy‐Hein, B. K., Gaylinn, B. D., Thorner, M. O., Hellerstein, M. K.

    Published in The FASEB journal (01-06-2008)
    “…Calorie restriction (CR) and alternate‐ day fasting (ADF) reduce cancer risk and reduce cell proliferation rates. Whether modified ADF regimens (i.e., allowing…”
    Get full text
    Journal Article
  8. 8

    A stable isotope-mass spectrometric method for measuring human spermatogenesis kinetics in vivo by Misell, L M, Holochwost, D, Boban, D, Santi, N, Shefi, S, Hellerstein, M K, Turek, P J

    Published in The Journal of urology (01-01-2006)
    “…Currently it is thought to take 60 to 70 days to produce and ejaculate human sperm. This estimate is derived mainly from a single older, descriptive, kinetic…”
    Get more information
    Journal Article
  9. 9

    Regulation of hepatic de novo lipogenesis in humans by Hellerstein, M.K. (University of California-Berkeley, Berkeley, CA.), Schwarz, J.M, Neese, R.A

    Published in Annual review of nutrition (01-01-1996)
    “…The enzymatic pathway for synthesis of fatty acids from acetyl-coenzyme A, or de novo lipogenesis (DNL), is present in human liver and, to a lesser extent, in…”
    Get full text
    Journal Article
  10. 10

    Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers by Hellerstein, M K, Neese, R A

    Published in The American journal of physiology (01-11-1992)
    “…Mass isotopomer distribution analysis (MIDA) is a technique for measuring biosynthesis and turnover of polymers in vivo. A stable isotopically enriched…”
    Get full text
    Journal Article
  11. 11

    T Cell Turnover in HIV-1 Disease by Hellerstein, M.K, McCune, J.M

    Published in Immunity (01-11-1997)
    “…A powerful "high turnover" model of human immunodeficiency virus type 1 (HIV-1) immunopathogenesis has been developed over the past several years. This model…”
    Get full text
    Book Review Journal Article
  12. 12

    Dynamic Proteomics: In Vivo Proteome-Wide Measurement of Protein Kinetics Using Metabolic Labeling by Holmes, W E, Angel, T E, Li, K W, Hellerstein, M K

    Published in Methods in enzymology (01-01-2015)
    “…Control of biosynthetic and catabolic rates of polymers, including proteins, stands at the center of phenotype, physiologic adaptation, and disease…”
    Get more information
    Journal Article
  13. 13

    Effect of pinitol treatment on insulin action in subjects with insulin resistance by A Davis, M Christiansen, J F Horowitz, S Klein, M K Hellerstein, R E Ostlund, Jr

    Published in Diabetes care (01-07-2000)
    “…Effect of pinitol treatment on insulin action in subjects with insulin resistance. A Davis , M Christiansen , J F Horowitz , S Klein , M K Hellerstein and R E…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption by SILER, S. Q, NEESE, R. A, HELLERSTEIN, M. K

    Published in The American journal of clinical nutrition (01-11-1999)
    “…Acute alcohol intake is associated with changes in plasma lipid concentrations and whole-body lipid balances in humans. The quantitative roles of hepatic de…”
    Get full text
    Journal Article
  15. 15
  16. 16

    No common energy currency: de novo lipogenesis as the road less traveled by Hellerstein, M K

    Published in The American journal of clinical nutrition (01-12-2001)
    “…Hellerstein discusses the role of de novo lipogenesis in energy production in animals. While scientists previously thought that animals used de novo…”
    Get full text
    Journal Article
  17. 17

    Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study by Hellerstein, M K, Neese, R A, Linfoot, P, Christiansen, M, Turner, S, Letscher, A

    Published in The Journal of clinical investigation (01-09-1997)
    “…Fluxes through intrahepatic glucose-producing metabolic pathways were measured in normal humans during overnight or prolonged (60 h) fasting. The glucuronate…”
    Get full text
    Journal Article
  18. 18

    Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection by Schwarz, J M, Neese, R A, Turner, S, Dare, D, Hellerstein, M K

    Published in The Journal of clinical investigation (01-12-1995)
    “…Short-term alterations in dietary carbohydrate (CHO) energy are known to alter whole-body fuel selection in humans, but the metabolic mechanisms remain…”
    Get full text
    Journal Article
  19. 19

    Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100 by Véniant, M M, Sullivan, M A, Kim, S K, Ambroziak, P, Chu, A, Wilson, M D, Hellerstein, M K, Rudel, L L, Walzem, R L, Young, S G

    Published in The Journal of clinical investigation (15-12-2000)
    “…Apo-E-deficient apo-B100-only mice (APOE:(-/-)APOB:(100/100)) and LDL receptor-deficient apo-B100-only mice (LDLR:(-/-)APOB:(100/100)) have similar total…”
    Get full text
    Journal Article
  20. 20

    Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia by Murphy, E J, Neuberg, D S, Rassenti, L Z, Hayes, G, Redd, R, Emson, C, Li, K, Brown, J R, Wierda, W G, Turner, S, Greaves, A W, Zent, C S, Byrd, J C, McConnel, C, Barrientos, J, Kay, N, Hellerstein, M K, Chiorazzi, N, Kipps, T J, Rai, K R

    Published in Leukemia (01-06-2017)
    “…The clinical course of patients with recently diagnosed early stage chronic lymphocytic leukemia (CLL) is highly variable. We examined the relationship between…”
    Get full text
    Journal Article